Cannabis Watch: Cannabis company Curaleaf draws downgrade to hold at Benchmark, while Wedbush sticks to outperform
Benchmark flags cannabis market “uncertainty” while Wedbush sees “good start” to 2023 after Curaleaf beats revenue target, posts narrower-than-expected loss.
Curaleaf Holdings Inc. drew a downgrade at Benchmark from buy to hold from Benchmark Research, while Wedbush opted to stick to its outperform rating after the cannabis companys first-quarter results….